The opening of the center was held: patients with erosive GERD will participate in an international, multicenter, prospective, randomized, double–blind, actively controlled, parallel-group study to evaluate the efficacy and safety of tegoprazane, sponsored by Dr. Reddy's Laboratories Ltd, India.




























